Myricetin and Hesperidin Inhibit Cerebral Thrombogenesis and Atherogenesis in Apoe-/- and Ldlr-/- Mice

ISSN Print: 2157-944X
ISSN Online: 2157-9458
www.scirp.net/journal/fns
E-mail: [email protected]

Citations

"Myricetin and Hesperidin Inhibit Cerebral Thrombogenesis and Atherogenesis in Apoe^-/- and Ldlr^-/- Mice"
written by Yasuto Sasaki, Kanae Hyodo, Ayana Hoshino, Eri Kisa, Koichi Matsuda, Yoko Horikawa, John C. Giddings,
published by Food and Nutrition Sciences, Vol.9 No.1, 2018

has been cited by the following article(s):

[1]	Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders
	CNS & Neurological …, 2024

[2]	Antihypertensive phytocomplexes of proven efficacy and well-established use: Mode of action and individual characterization of the active constituents
	2020

[3]	Antihypertensive phytocomplexes of proven efficacy and weel-established use: mode of action and individual characterization of the active constituents
	…, 2019

[4]	基因敲除动脉粥样硬化小鼠模型研究进展
	研究, 2019

[1]	Myricetin alleviates high-fat diet-induced atherosclerosis in ApoE−/− mice by regulating bile acid metabolism involved in gut microbiota remodeling Food & Function, 2025 DOI:10.1039/D5FO00374A

[2]	Pharmacological, medicinal and biological properties of flavonoids: A comprehensive review Journal of Research in Pharmacy, 2025 DOI:10.12991/jrespharm.1661054

[3]	Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders CNS & Neurological Disorders - Drug Targets, 2024 DOI:10.2174/1871527322666230718105358

Top